Description

The Cardiac Marker Test models YRA363 and YRA367 are specifically designed to meet the highest standards in cardiovascular diagnostics. These kits are primarily utilized with IVD CLIA Analyzers and incorporate advanced chemiluminescence technology to effectively detect crucial cardiac biomarkers such as NT-ProBNP and hs-cTnI. With a patented magnetic separation technology, these tests not only offer high sensitivity and stability but also assure reliable outcomes for critical medical assessments. Compatible with Chemiluminescence Immunoassay Analyzer models YR06387 and YR06388, these kits provide a sophisticated yet user-friendly solution for comprehensive cardiac disease testing. Experience the forefront of diagnostic innovation and ensure accurate cardiovascular assessments by integrating these advanced tools into your medical practice. Ready to upgrade your diagnostic capabilities? Request a quote or generate one automatically through Kalstein Plus now.

Market Price

In the competitive landscape of medical diagnostics, the pricing of Cardiac Marker Test kits such as YRA363 and YRA367 varies, generally ranging from $500 to $1500 per kit based on volume and distribution agreements. These price variations account for their innovative features and high-precision materials, ensuring effective and reliable diagnostics. Quantity orders may further influence pricing, providing flexibility for different healthcare setups.

Frequently Asked Questions

What is the primary use of the Cardiac Marker Test? These tests are primarily used for detecting cardiac biomarkers to assess heart function and diagnose potential cardiovascular diseases.

How does the chemiluminescence technology enhance the test’s accuracy? The technology utilizes an enzymatic chemiluminescence process that ensures high sensitivity and stability, providing accurate and consistent results.

Advantages and Disadvantages

The Cardiac Marker Test kits offer numerous advantages, including high sensitivity, ease of automation, and the elimination of radioactive hazards. On the downside, they require specific compatible analyzers (models YR06387 and YR06388) for operation, which can be a limitation if these models are not available within existing setups.

Product Use in the Field

Healthcare professionals employ Cardiac Marker Tests in clinical environments to assess patients with heart disease symptoms. These tests facilitate timely decision-making by providing quick results through automated processes, making them indispensable in both emergency diagnostics and routine health check-ups.

Recommendations

To ensure optimal performance, it is recommended to store the kits at a controlled temperature of 2-8°C and use them with the specific analyzers noted. Regular calibration and adherence to the manufacturer’s guidelines will maintain the accuracy and efficiency of the tests.

Features

– Advanced chemiluminescent detection technology

– Compatible with specific CLIA Analyzers

– High sensitivity and stability

– Magnetic separation for precise results

Technical Specifications